Health
Messenger RNA vaccines lower risk for asymptomatic infection, study finds – Healio
Participants who received two doses of a messenger RNA COVID-19 vaccine were 80% less likely to test positive for asymptomatic SARS-CoV-2, according to real-world…
Participants who received two doses of a messenger RNA COVID-19 vaccine were 80% less likely to test positive for asymptomatic SARS-CoV-2, according to real-world study results published in Clinical Infectious Diseases.
Even after one dose, the risk for asymptomatic infection was reduced by 79%, researchers reported. The two messenger RNA vaccines authorized for use in the United States are made by Pfizer-BioNTech and Moderna.
“As people are undergoing their routine care and they’re caring for…
-
Business21 hours agoZip shares rocketed 32% in August. Here’s how
-
Business18 hours agoDown more than 20% this year, does Macquarie rate Boss Energy shares a buy?
-
General20 hours agoKids unknowingly targeted with AI abuse apps, images
-
Business23 hours agoGold price alert! Macquarie reveals its top ASX 200 gold stock as the metal hits all-time high